Denali Therapeutics
Denali Therapeutics is seeking a Medical Director, Clinical Development to provide clinical leadership for enzyme replacement programs and advance innovative therapies for neurodegenerative and rare diseases. The role involves shaping clinical strategy, overseeing trial design and execution, and collaborating cross-functionally to support the development of biotherapeutics that cross the blood-brain barrier. This position offers an opportunity for a physician or physician-scientist to lead clinical science efforts and mentor team members within a dynamic biotechnology environment.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2015
Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. We discover, develop and deliver medicines for people living with serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Denali Therapeutics.
30% above the average for this role
Senior Director, Clinical Research - Neurodegeneration
Alnylam Pharmaceuticals
Director, Clinical Scientist
Spyre Therapeutics
Director, Translational Science (Neurology)
Eisai
Director Clinical Research Cns United States
alnylam
Principal Scientist (Clinical Director) in Translational Medicine/Early Clinical Development in the Respiratory Therapeutic Area
Merck & Co., Inc.
SVP, Clinical Development
Amylyx Pharmaceuticals